Evidence map›Paper›PMID 30603365›Full record

ArticleDiabetology international2018

Development of a novel estimation method for hemoglobin A1c using glycated albumin in type 2 diabetes mellitus patients with end-stage renal disease.

Akihiko Nakamura, Ryo Kodera, Noriko Sakamoto, Haruyo Ujike, Jun Wada, Kenichi Shikata, Hirofumi Makino

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Diabetology international, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Akihiko NakamuraOsafune Clinic, 332-1 Haji, Osafune, Setouchi, Okayama 701-4264 Japan.
Ryo KoderaOsafune Clinic, 332-1 Haji, Osafune, Setouchi, Okayama 701-4264 Japan.ORCID 0000-0003-3401-9546
Noriko SakamotoDiabetes, Metabolism, and Endocrinology, Shin Kashiwa Clinic, 1-7, Shinkashiwa, Kashiwa, Chiba Japan.
Haruyo Ujike4Departments of Nephrology, Kagawa Prefectural Central Hospital, 1-2-1, Asahi, Takamatsu, Kagawa Japan.
Jun Wada5Dentistry and Pharmaceutical Sciences, Medicine and Clinical Science, Okayama University Graduate School of Medicine, 2-5-1 Shikata, Kita-ku, Okayama, Japan.
Kenichi Shikata2Center for Innovative Clinical Medicine, Okayama University Hospital, 2-5-1 Shikata, Kita-ku, Okayama, Japan.
Hirofumi Makino6Okayama University Hospital, 2-5-1 Shikata, Kita-ku, Okayama, Japan.
Okayama University Hospital · JPOkayama University · JPKashiwa Municipal Hospital · JPOptica · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimWe developed a novel estimation method for hemoglobin A1c (HbA1c) in type 2 diabetes (T2D) patients with end-stage renal disease (ESRD). This method is based on the glycated albumin (GA) level.

methodsOf the 788 Japanese patients with T2D included in this study, 545 had normal renal function (NRF group) and 243 had ESRD. Oral glucose tolerance tests (OGTTs) were performed in 80 subjects. The variables GA, body mass index (BMI), hemoglobin (Hb), and estimated glomerular filtration rate (eGFR) were significantly associated with the GA-to-HbA1c ratio and were used to determine the estimated HbA1c (eHbA1c). One method of estimating HbA1c involved dividing GA by the GA-to-HbA1c ratio predicted from the estimated regression equation; the estimated HbA1c obtained in this manner was denoted eHbA1c-1.

resultseHbA1c-1 (%) = GA × [4.688 - 18.833 × GA

conclusionseHbA1c-1 may be a useful parameter for estimating HbA1c in T2D patients with ESRD.

Indexed as

End-stage renal diseaseGlycated albuminHemoglobin A1cType 2 diabetes

Identifiers

PMID30603365
PMCPMC6224914
OpenAlexW2787088585

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.